A study of FH-006 for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called FH-006 for people with advanced solid tumors that cannot be surgically removed or have spread. It aims to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor that cannot be removed by surgery or has spread to other parts of the body.
- You have at least one tumor that can be measured on scans.
- You are able to take care of yourself and perform daily activities (ECOG score 0 or 1).
- Your major organs are working well enough, as determined by blood and other tests.
- Your expected survival is at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called FH-006 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.
This study tests a new drug called HC006 for advanced solid tumors that no longer respond to standard treatments. It aims to find a safe dose and see if it helps shrink tumors.
This trial tests a new drug called MHB009C for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug is safe and effective.
This trial tests an injection called MHB118C for people with advanced solid tumors that have stopped responding to standard treatments or have no standard options. The goal is to see if this new drug can help shrink tumors or slow their growth.
This trial tests a new drug, SHR-4506, for people with advanced cancers that have stopped responding to standard treatments or cannot be treated with standard options. It aims to see if the drug is safe and helpful.
This trial tests a new drug called FH-006 combined with other cancer therapies for people with advanced non-small cell lung cancer that cannot be removed with surgery or treated with radiation. It aims to see if this combination can help shrink tumors or slow cancer growth.
Hear when a new Malignant Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.